United States Senate Passes Opioids Bill

Share this content:
The Opioid Crisis Response Act authorizes $7.9 billion for the CDC and other agencies.
The Opioid Crisis Response Act authorizes $7.9 billion for the CDC and other agencies.

(HealthDay News) -- The Senate on Monday passed on a 99-1 vote legislation aimed at curbing the nation's ongoing opioid addiction crisis.

The comprehensive bipartisan package earmarks billions of dollars to prevent cross-border opioid trafficking, create comprehensive recovery centers, and fund research into helping children exposed to opioid abuse, CBS News reported.

Five different committees submitted more than 70 proposals to help craft the bill, called the Opioid Crisis Response Act of 2018. The bill authorizes $7.9 billion for the U.S. Centers for Disease Control and Prevention, the Department of Health and Human Services, and other agencies.

The bill includes the Synthetics Trafficking and Overdose Prevention Act, or STOP, which requires the U.S. Postal Service to do more to prevent illegal drugs such as fentanyl from entering the United States via the mail. The bill also mandates that the U.S. Food and Drug Administration oversee the design of new packaging for opioids in limited quantities -- for example, a three- or seven-day supply in plastic blister packs. Ten million dollars in grant money will also be given to qualified applicants to open addiction recovery centers, CBS said.

The House passed its own version of the bill in June, and the Senate and House are expected to iron out any differences between the two bills by Friday, so that a bill can be presented to President Donald Trump for signature by early October.

CBS News Article

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs